GULF TIME Memorial Sloan Kettering Cancer Center (MSK), a global leader in cancer care and ...
Read More »Shareholders of Japan’s Takeda ‘skeptical’ of its Shire takeover
Bloomberg One of the top 10 shareholders in Japanese drugmaker Takeda Pharmaceutical Co. is “skeptical†on the value that will be created from the group’s $62 billion takeover of rare disease specialist Shire Plc, the Sunday Times reported, citing the unidentified investor. The deal, the biggest in Osaka-based Takeda’s history, has already faced opposition from a group of investors that ...
Read More »